Oxidative stress has been closely related with coronary artery disease. In coronary heart
disease (CHD), an excess of reactive oxygen species (ROS) production generates endothelial …

Some well-established immunotherapy, radiotherapy, postoperation, anticancer drugs such
as anthracyclines, antimetabolites, human epidermal growth factor receptor 2 blockers, …

Objectives To examine heterogeneity of outcomes in protocols of clinical trials of Coronavirus
Disease 2019 (COVID-19) and to identify outcomes for prioritization in developing a core …

Background Development of a core outcome set (COS) for clinical trials for COVID-19 is urgent
because of the pandemic wreaking havoc worldwide and the heterogeneity of outcomes …

Ethnopharmacological relevance Fangji is an ancient combinatorial formula. The compatibility
mechanisms that how component herbs of Fangji work cooperatively to achieve the …

Introduction Myocardial infarction (MI) is the most dangerous complication in patients with
coronary heart disease. In China, there is an increasing number of randomised controlled …

Objectives To examine variation in outcomes, outcome measurement instruments (OMIs) and
measurement times in clinical trials of non-valvular atrial fibrillation (NVAF) and to identify …

Backgrounds Traditional Chinese medicine and Western medicine combination (TCM-WMC)
increased the complexity of compounds ingested. Objective To develop a method for …

A core outcome set (COS) is an agreed minimum set of outcomes that should be reported in
all clinical trials in specific areas of health care. The use of COS can reduce the …

Background No treatment has convincingly been proven to be beneficial for microvascular
obstruction (MVO) in patients with ST-elevation myocardial infarction (STEMI). Several studies …